Additionally, a previously unknown mutation was identified in the ATP1A2 gene p.Thr570Met in association with EA2 symptoms, confirming the difficulty to differentiate between the clinical features of EA2 and FHM for a precise clinical diagnosis. This evidence concerns the gene ATP1A2 and familial hemiplegic migraine.